![]() ![]() ![]() Expert faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. ASCO’s growing roster of cutting-edge journals serves readers as the most credible, authoritative, peer-reviewed resources for. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to, CAR-T therapy and T-cell redirecting bispecific antibodies. ASCO Daily News is the official conference reporter for ASCO meetings and symposia, providing high-quality, unbiased research summaries and oncology news to members and oncology health care providers. The conferences will take place between November 24 and 27, at the International Hotel in Iai. ![]() The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. We have the great honor and pleasure to invite you to one of the most important multidisciplinary events in the area of national oncology, CONFER 2016. This CME-accredited activity “Multiple Myeloma & Lymphoma Summit” features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |